HBV DNA qualitative + drug resistance (YMDD)
The test detects the genetic material (DNA) of the HBV virus, the causative agent of hepatitis B, and checks whether it is resistant to drugs, helping to treat it more effectively

Synevo
Lowest price from 30 days before discounting PLN 1,262.00
- Test description
- Documents
HBV DNA quality + drug resistance (YMDD)
Clinical significance
HBV - a virus of the Hepadnaviridae family, causing hepatitis B. Infection occurs by the parenteral route, mainly through the blood, sexually or perinatally. The main reservoir of infection is the sick person. The test involves qualitative detection of HBV DNA and determination of drug resistance.
Patient preparation
Material: Serum